Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /backoffice/ /pdf/ Sitemap: |
Title | Jubilant Therapeutics | Oncology | |
Description | Creating breakthrough small molecule therapeutics for genetically-defined cancers and autoimmune About Us Company Overview Our Team Strategic Advisors Scientific Advisors Board of Directors Our Strategy Pipeline Overview LSD1/HDAC6 PRMT5 PAD4 PD-L1 Pu |
Keywords | Biopharmaceutical, Precision Medicines, Small Molecule Modulators, Oncology, Autoimmune |
WebSite | jubilanttx.com |
Host IP | 15.207.250.120 |
Location | United Kingdom |
Site | Rank |
US$5,337,938
Last updated: 2023-05-16 21:09:30
jubilanttx.com has Semrush global rank of 1,982,845. jubilanttx.com has an estimated worth of US$ 5,337,938, based on its estimated Ads revenue. jubilanttx.com receives approximately 615,916 unique visitors each day. Its web server is located in United Kingdom, with IP address 15.207.250.120. According to SiteAdvisor, jubilanttx.com is safe to visit. |
Purchase/Sale Value | US$5,337,938 |
Daily Ads Revenue | US$4,928 |
Monthly Ads Revenue | US$147,820 |
Yearly Ads Revenue | US$1,773,838 |
Daily Unique Visitors | 41,062 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
jubilanttx.com. | A | 28800 | IP: 15.207.250.120 |
jubilanttx.com. | NS | 38400 | NS Record: panalink.earth.orderbox-dns.com. |
jubilanttx.com. | NS | 38400 | NS Record: panalink.mercury.orderbox-dns.com. |
jubilanttx.com. | NS | 38400 | NS Record: panalink.mars.orderbox-dns.com. |
jubilanttx.com. | NS | 38400 | NS Record: panalink.venus.orderbox-dns.com. |
jubilanttx.com. | MX | 28800 | MX Record: 0 jubilanttx-com.mail.protection.outlook.com. |
jubilanttx.com. | TXT | 28800 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
jubilanttx.com. | TXT | 28800 | TXT Record: MS=ms39360837 |
About Us Company Overview Our Team Strategic Advisors Scientific Advisors Board of Directors Our Strategy Pipeline Overview LSD1/HDAC6 PRMT5 PAD4 PD-L1 Publications News & Events Events Press Releases Corporate Presentation Careers Overview Code of Conduct Whistle Blower Policy Collaborations About Us Company Overview Our Team Strategic Advisors Scientific Advisors Board of Directors Our Strategy Pipeline Overview LSD1/HDAC6 PRMT5 PAD4 PD-L1 Publications News & Events Events Press Releases Corporate Presentation Careers Overview Code of Conduct Whistle Blower Policy Collaborations Contact Us Leveraging Innovation for Precision Medicine Leverages decades of drug discovery and development expertise to deliver precision medicines --> Contact Us What are you looking for? × What are you looking for? --> Creating breakthrough small molecule therapeutics for genetically-defined cancers and autoimmune disorders First-in-class programs with fast-track and breakthrough potential advancing |
HTTP/1.0 302 Moved Temporarily Location: https://jubilanttx.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Content-Length: 149 Content-Type: text/html; charset=UTF-8 Location: http://www.jubilanttx.com/ Vary: Accept-Encoding Access-Control-Allow-Origin: * Access-Control-Allow-Methods: GET,PUT,POST,DELETE,OPTIONS Access-Control-Allow-Headers: Content-Type Date: Tue, 15 Feb 2022 08:34:29 GMT Connection: close P3P: CP="{}" Set-Cookie: TS8cc3207d029=08143b4a96ab28009c0ab7c832e74f6953080334baf02cf05293cf8534864c7dbb1885629b1e14148a50cf4897e37158; Max-Age=30;Path=/ P3P: CP="{}" Set-Cookie: TS3c1dd8b7027=08143b4a96ab2000b1cb94ed69fa97349469499c69fce5447b671539e003f9c7918e3a2d2349f4dc08a1d3228e1130003728ed30ef32975e688a3bb0923a749697321886e89ac8e5fdb50e9b74b18a7030a3b4a3c2a0547907ccb7608a726dba;Path=/ HTTP/1.0 302 Moved Temporarily Location: https://www.jubilanttx.com/ Connection: close Content-Length: 0 HTTP/1.1 200 OK Cache-Control: private Content-Type: text/html; charset=utf-8 Vary: Accept-Encoding Access-Control-Allow-Origin: * Access-Control-Allow-Methods: GET,PUT,POST,DELETE,OPTIONS Access-Control-Allow-Headers: Content-Type Date: Tue, 15 Feb 2022 08:34:32 GMT Connection: close P3P: CP="{}" Set-Cookie: TS8cc3207d029=08143b4a96ab28009a35e392f873cd9fc14f24beaa2b7af62fdfb98483954065dbf376810a402a1050e826d702356bc5; Max-Age=30;Path=/ P3P: CP="{}" Set-Cookie: TS3c1dd8b7027=08143b4a96ab2000f59851c148a29e923aa41c42d10e771a7714f4fd31ab94af2e8e8d7e5cf14c5d088a9815e8113000de445a0bdd806e7731eacf48d7fff03e124234e83bfca7cfda409b9b519f18144a652337bc62fece71731b26e8b7fb67;Path=/ Via: 1.1 dca1-bit10021 Set-Cookie: TS01ae2013=01444dd813642bac8f234fd9a33134e16b9323955156dd77acfe17ca0630b50a780feb907b77482a5de8bab76813536f884a04517fb333ec6e8d0a24ca2713e665e89407c03fe0c05d97886d61995376e916942bd3; Path=/; Secure; HTTPOnly |
Domain Name: JUBILANTTX.COM Registry Domain ID: 2469468864_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.PublicDomainRegistry.com Registrar URL: http://www.publicdomainregistry.com Updated Date: 2020-04-13T09:46:38Z Creation Date: 2019-12-20T09:46:35Z Registry Expiry Date: 2024-12-20T09:46:35Z Registrar: PDR Ltd. d/b/a PublicDomainRegistry.com Registrar IANA ID: 303 Registrar Abuse Contact Email: abuse-contact@publicdomainregistry.com Registrar Abuse Contact Phone: +1.2013775952 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: PANALINK.EARTH.ORDERBOX-DNS.COM Name Server: PANALINK.MARS.ORDERBOX-DNS.COM Name Server: PANALINK.MERCURY.ORDERBOX-DNS.COM Name Server: PANALINK.VENUS.ORDERBOX-DNS.COM DNSSEC: unsigned >>> Last update of whois database: 2022-02-15T08:13:07Z <<< |